Enlisense LIMITED Liability Company
Allen, TX
- UEI
- M8E8RD7W5FR1
- CAGE
- 7AX78
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 1813 Audubon Pond Way, Allen, TX 75013, USA
- Website
- enlisense.com
- Founded
- 2014
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Mayo Clinic | 140D042490004 | $1,093,666 | |
| The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | W911QY2090004 | $174,640 | |
| Mayo Clinic | 140D042490004 | $846,680 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Aware (a wearable awareness with real-time exposure): rapid wearable alcohol diagnostics | National Institute on Alcohol Abuse and Alcoholism (NIH) | $242,333 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | N626451920001 | $137,280 |
Similar vendors
About the company
Enlisense LIMITED Liability Company (doing business as Enlisense LLC), a minority-owned, Subcontinent Asian American-owned for-profit Subchapter S corporation based in Allen, Texas, develops diagnostic biosensor platforms and wearable medical devices for federal health research and military medical countermeasure programs, primarily as a subcontractor to research foundations and defense primes rather than as a direct federal prime.
Enlisense operates predominantly in a subcontractor role, with 67% of recent awards (four of six) placed under primes including the Henry M. Jackson Foundation for the Advancement of Military Medicine and Mayo Clinic. The company's core capability centers on point-of-care diagnostic cartridge systems and sweat-based biosensor platforms for biomarker detection. In its largest recent subcontract work, Enlisense is developing wearable sensor panels to detect anti-TNF-alpha monoclonal antibodies and inflammatory biomarkers (CRP, IL-6) in sweat under Mayo Clinic's EASE-REACT program; the work involves sensor manufacturing, integration, and clinical validation with human subjects. Under the Henry M. Jackson Foundation, Enlisense is delivering cartridge-based C-reactive protein assay optimization on its READ HDx platform for COVID-19 medical countermeasure evaluation, and previously developed melioidosis diagnostic systems for the Austere Environments Consortium for Enhanced Sepsis Outcomes (ACESO) program, which serves U.S. expeditionary forces.
Customer concentration is distributed across five federal agencies, all within the Department of Health and Human Services (two awards from the National Institutes of Health) and health-aligned components of the Department of the Navy and Department of the Army. The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response accounts for the single largest declared potential value of $504 thousand, though combined obligated dollars across all awards ($3 million) substantially exceed reported potential value, indicating research grant funding patterns typical of NIH sub-recipient work. Activity is sparse but recent: six total awards spanning 2017 to November 2025, with two awards placed in 2025. The vendor has not been awarded a direct federal prime contract or IDV; all work flows through research foundation and military primes serving as federal grant recipients or prime contractors.
Quick answers
Is Enlisense LIMITED Liability Company registered in SAM.gov?
Yes. Enlisense LIMITED Liability Company's SAM.gov registration is active through January 13, 2027.
What is Enlisense LIMITED Liability Company's most recent federal award?
Enlisense LIMITED Liability Company's most recent federal grant award is Aware (a wearable awareness with real-time exposure): rapid wearable alcohol diagnostics (R43AA026114), from National Institute on Alcohol Abuse and Alcoholism (NIH), on September 1, 2017.
On GovTribe
See Enlisense LIMITED Liability Company's full federal record
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors